- Home
- TRDA vs EOD Comparison
TRDA vs EOD Comparison
Compare TRDA & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- EOD
- Stock Information
- Founded
- TRDA 2016
- EOD 2007
- Country
- TRDA United States
- EOD United States
- Employees
- TRDA N/A
- EOD N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- EOD Investment Managers
- Sector
- TRDA Health Care
- EOD Finance
- Exchange
- TRDA Nasdaq
- EOD Nasdaq
- Market Cap
- TRDA 233.5M
- EOD 245.0M
- IPO Year
- TRDA 2021
- EOD N/A
- Fundamental
- Price
- TRDA $5.33
- EOD $5.68
- Analyst Decision
- TRDA Strong Buy
- EOD
- Analyst Count
- TRDA 3
- EOD 0
- Target Price
- TRDA $25.67
- EOD N/A
- AVG Volume (30 Days)
- TRDA 223.5K
- EOD 118.1K
- Earning Date
- TRDA 11-04-2025
- EOD 01-01-0001
- Dividend Yield
- TRDA N/A
- EOD 9.28%
- EPS Growth
- TRDA N/A
- EOD N/A
- EPS
- TRDA N/A
- EOD N/A
- Revenue
- TRDA $79,476,000.00
- EOD N/A
- Revenue This Year
- TRDA N/A
- EOD N/A
- Revenue Next Year
- TRDA N/A
- EOD N/A
- P/E Ratio
- TRDA N/A
- EOD N/A
- Revenue Growth
- TRDA N/A
- EOD N/A
- 52 Week Low
- TRDA $4.93
- EOD $3.73
- 52 Week High
- TRDA $21.79
- EOD $4.71
- Technical
- Relative Strength Index (RSI)
- TRDA 44.26
- EOD 50.31
- Support Level
- TRDA $5.08
- EOD $5.64
- Resistance Level
- TRDA $5.39
- EOD $5.80
- Average True Range (ATR)
- TRDA 0.25
- EOD 0.04
- MACD
- TRDA 0.02
- EOD -0.00
- Stochastic Oscillator
- TRDA 24.53
- EOD 25.00
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.